Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-01-28FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Viona Pharmaceuticals Inc)
The FDA approved a supplemental application for Metformin hydrochloride from Viona Pharmaceuticals Inc, indicating changes to an already app…
-
FDA approval · 2008-01-28FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Viona Pharmaceuticals Inc)
FDA approved a supplemental application for Metformin Hydrochloride (Viona Pharmaceuticals Inc), reflecting a change to the labeling under a…
-
FDA approval · 2008-01-18FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2008-01-11FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BYETTA (exenatide) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2008-01-03FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's metformin hydrochloride generic under an Original Application (ANDA). The approval makes a met…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-01-02FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for JANUMET (sitagliptin/metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2007-11-14FDA Approved: GLYBURIDE AND METFORMIN HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved an original ANDA for Glyburide and Metformin Hydrochloride tablets from Aurobindo Pharma Limited.
-
FDA approval · 2007-11-13FDA Approved: GLIMEPIRIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for generic glimepiride submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2007-10-11FDA Approved: JANUMET — Supplemental Application (Merck Sharp & Dohme LLC)
The FDA approved a supplemental application for JANUMET (sitagliptin and metformin hydrochloride) submitted by Merck Sharp & Dohme LLC.
-
FDA approval · 2007-10-01FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for a pioglitazone and glimepiride fixed-dose combination from Prasco Laboratories.
-
FDA approval · 2007-09-26FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA supplemental application approval for a fixed-dose combination of pioglitazone and glimepiride, filed by Prasco Laboratories.
-
FDA approval · 2007-09-26FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for ACTOPLUS MET (pioglitazone and metformin hydrochloride) from Takeda Pharmaceuticals America,…
-
FDA approval · 2007-09-10FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2007-09-07FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2007-09-07FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2007-09-07FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company. This action updates th…
-
FDA approval · 2007-09-06FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Pioglitazone and Glimepiride from Prasco Laboratories to market a fixed-dose combination product…
-
FDA approval · 2007-09-06FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2007-09-06FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company.
-
FDA approval · 2007-09-06FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humalog Mix50/50 KwikPen (insulin lispro mix 50/50) from Eli Lilly, authorizing the KwikPen deli…
-
FDA approval · 2007-09-06FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX75/25 (insulin lispro) from Eli Lilly and Company. The action involves an additional …
-
FDA approval · 2007-08-27FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Welchol (colesevelam hydrochloride) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2007-08-23FDA Approved: GLIMEPIRIDE — Original Application (Accord Healthcare Inc)
FDA approved Accord Healthcare Inc.'s Original Application (ANDA) for a generic form of glimepiride. Glimepiride is used to treat type 2 dia…
-
FDA approval · 2007-08-22FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly and Company (including the associated diluent).
-
FDA approval · 2007-08-22FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.